Add to Favorites Newsroom RSS Share
New Brunswick, NJ USA

Our News on Newswise


Rutgers Cancer Institute of New Jersey Biospecimen Repository and Histopathology Service Shared Resource Receives Accreditation from College of American Pathologists

The Biospecimen Repository and Histopathology Service shared resource at Rutgers Cancer Institute of New Jersey has received accreditation from the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the...
15-Oct-2018 3:05 PM EDT Add to Favorites


Better Survival Outcomes for Advanced Prostate Cancer Patients Treated with Surgery followed by Radiation than with Radiation plus Hormone Therapy

Newly published results of a study examining men with locally or regionally advanced prostate cancer show those treated with a radical prostatectomy followed by radiation treatment have a lower risk of death from prostate cancer and improved overall...
20-Sep-2018 4:05 PM EDT Add to Favorites


Revisiting the Mode of Cancer Evolution

Analysis by investigators at Rutgers Cancer Institute of New Jersey further examines tumor evolution through genomic data captured from thousands of cancer tumor samples using a mathematical model.
21-Sep-2018 3:30 PM EDT Add to Favorites


New Chief of Breast Surgery Named at Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey has named M. Michele Blackwood, MD, FACS, as its new Chief of Breast Surgery. Dr. Blackwood, whose surgical expertise is in complex breast malignancies, is currently the Medical Director and Northern Regional...
17-Sep-2018 8:00 AM EDT Add to Favorites


Study of Breast Cancer Subtype among New Jersey Women Shows Disparities by Age, Race, and Hispanic-Origin

When it comes to breast cancer subtype in the Garden State, researchers from Rutgers University and the New Jersey State Cancer Registry find that non-Hispanic black women and women between the ages of 20 to 39 have higher rates of triple-negative...
13-Sep-2018 1:45 PM EDT Add to Favorites


Clinical Trial Shows Best Outcomes to Date for Older Hodgkin Lymphoma Patients

Recently published results of a phase 2 clinical trial have shown the best outcomes to date for newly diagnosed older Hodgkin lymphoma patients treated with brentuximab vedotin given before and after doxorubicin, vinblastine and dacarbazine (AVD)...
4-Sep-2018 12:05 PM EDT Add to Favorites


$500K Grant Aids Exploration of Genetic Changes in Pancreatic Cancer for New Treatment Targets

A $500,000 grant from the Pancreatic Cancer Action Network will help a Rutgers Cancer Institute of New Jersey physician-scientist explore a biological event associated with a signaling pathway known as Netrin-1 that enables cancer cells to live.
23-Aug-2018 8:00 AM EDT Add to Favorites


$500K Pledge from Hugs for Brady Foundation Supports Dedicated Laboratory Space for Pediatric Cancer Research at Rutgers Cancer Institute of New Jersey

The Hugs for Brady Foundation has announced a $500,000 pledge to Rutgers Cancer Institute of New Jersey to support a dedicated laboratory space for pediatric cancer research.
21-Aug-2018 2:05 PM EDT Add to Favorites

see all news

Our Experts on Newswise


September is Sickle Cell Disease Awareness Month

Sickle cell disease is a common inherited blood disorder, affecting an estimated 100,000 Americans of different racial and ethnic groups. A Rutgers Cancer Institute of New Jersey expert shares more about the importance of early diagnosis and...
24-Sep-2018 8:00 AM EDT


Thyroid Cancer 101

While thyroid cancers are common, they may not be as widely understood as other common cancers such as breast or prostate. A Rutgers Cancer Institute of New Jersey expert shares more about the butterfly-shaped gland in the lower neck and how...
18-Sep-2018 8:00 AM EDT


Ovarian Cancer: What You Need to Know

During this Gynecologic Cancers Awareness Month, a Rutgers Cancer Institute of New Jersey expert shares info on symptoms and treatment of ovarian cancer.
14-Sep-2018 12:00 PM EDT


Prostate Cancer PSA Screening: Finding Clarity in Confusion

With recent changes in recommendations for PSA testing for prostate cancer, confusion may exist for those considering the screening. A Rutgers Cancer Institute of New Jersey expert shares what one needs to know when discussing the topic with his...
13-Sep-2018 8:05 AM EDT


Palliative Care: Another Level of Support in the Cancer Journey

With word this week that former PGA Tour golfer Jarrod Lyle is transitioning from treatment for acute myeloid leukemia to palliative care, one might wonder what that form of care entails. A Rutgers Cancer Institute of New Jersey expert shares more...
1-Aug-2018 7:05 AM EDT


Checking in (and Checking up) on Dad this Father’s Day

Instead of another tie or tools, give the gift of good health this Father’s Day. As Rutgers Cancer Institute of New Jersey experts note, it’s as simple as encouraging regular health screenings to protect against cancer.
14-Jun-2018 4:05 PM EDT


Sun Safety: Planning is Your Best Protection

Longer days means more exposure to the sun and harmful UV rays. A Rutgers Cancer Institute of New Jersey expert shares some tips on how to keep your skin safe this season and all year long.
24-May-2018 9:20 AM EDT


A Closer Look at the Association Between Breast Implants and an Uncommon Form of Cancer

Updated statistics from the U.S. Food and Drug Administration out this month show that over the previous year, there has been an increase in cases of an uncommon form of cancer associated with breast implants. Rutgers Cancer Institute of New...
28-Mar-2018 8:00 AM EDT

see all experts

Our YouTube Videos


As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey is dedicated to improving the prevention, detection, treatment, and care of patients with cancer, through the transformation of laboratory discoveries into clinical practice. Rutgers Cancer Institute of New Jersey delivers advanced comprehensive care to adults and children including access to clinical trials and conducts cutting-edge cancer research.

The coveted NCI designation, awarded to only 47 such centers nationwide, is granted competitively to institutions characterized by scientific excellence and the ability to bring research discoveries to patients. To gain a "comprehensive" designation, the highest ranking given by the NCI, a center must meet rigorous criteria in cancer care, research, prevention and education.

The leadership of Rutgers Cancer Institute is comprised of distinguished researchers and physicians who are internationally recognized in their field. Basic scientists, clinical researchers, and population scientists meet regularly to exchange information and ensure that laboratory discoveries are refined and applied to clinical care as quickly as possible, that clinical observations reach laboratory researchers on a continuing basis, and that prevention strategies are interwoven in to all research programs.


Main Box
Program Assistant


Michele Fisher
Media Relations Specialist


Kristen Fuge
Program Assistant



Chat now!